Cancer risk in patients with manifest vascular disease: Effects of smoking, obesity, and metabolic syndrome

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 7, 2013, Pages 1267-1277

  Van Kruijsdijk, Rob C M ^a   Van Der Graaf, Yolanda ^a   Peeters, Petra H M ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLADDER CANCER; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; INTRAABDOMINAL FAT; KIDNEY CANCER; LIP CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOUTH CANCER; OBESITY; PHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; STANDARDIZED INCIDENCE RATIO; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASMS; NETHERLANDS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; VASCULAR DISEASES;

EID: 84880029581     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0090     Document Type: Article

References (45)

1. Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 2007;298:1412-9. (Pubitemid 47481607)
2. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93. (Pubitemid 41642642)
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. (Pubitemid 43767064)
5. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)*Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-701.
6. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. (Pubitemid 43947981)
7. Doll R. Uncovering the effects of smoking: historical perspective. Stat Methods Med Res 1998;7:87-117. (Pubitemid 28294000)
8. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105. (Pubitemid 29466221)
9. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-43. (Pubitemid 30205068)
10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
11. IARC. Handbooks of cancer prevention: weight control and physical activity. Lyon, France: International Agency for Research on Cancer Press; 2002.
12. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
13. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
14. van Kruijsdijk RCM, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569-78.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
16. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006;169:1505-22. (Pubitemid 351181984)
17. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012;35:2402-11.
18. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86:s836-42.
19. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004;173:363-9. (Pubitemid 38469808)
20. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
21. van der Leeuw J, Wassink AM, van der Graaf Y, Westerveld HE, Visseren FL. Age-related differences in abdominal fat distribution in premenopausal and postmenopausal women with cardiovascular disease. Menopause 2012 Nov 19. [Epub ahead of print]
22. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001;25:1346-51. (Pubitemid 32835453)
23. The Netherlands Cancer Registry [cited June 2012]. Available from: http://www.cijfersoverkanker.nl.
24. Statistics Netherlands [cited June 2012]. Available from: http://statline.cbs.nl/statweb/?LA=NL.
25. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
26. World Health Organisation. International classification of diseases for oncology. 3rd ed. Geneva, Switzerland: WHO; 2000.
27. Phipps AI, Ichikawa L, Bowles EJ, Carney PA, Kerlikowske K, Miglioretti DL, et al. Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 2010;67:60-6.
28. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91. (Pubitemid 44374314)
29. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
30. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010;45:1388-95.
31. Dreyer L, Olsen JH. Cancer risk of patients discharged with acute myocardial infarct. Epidemiology 1998;9:178-83. (Pubitemid 28158942)
32. Pehrsson SK, Linnersjo A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Intern Med 2005;258:124-32. (Pubitemid 41025969)
33. Reicher-Reiss H, Jonas M, Goldbourt U, Boyko V, Modan B. Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol 2001;87:459-62,A6.
34. Henderson BE, Bogdanoff E, Gerkins VR, SooHoo J, Arthur M. Evaluation of cancer risk factors in a retirement community. Cancer Res 1974;34:1045-8.
35. Neugut AI, Rosenberg DJ, Ahsan H, Jacobson JS, Wahid N, Hagan M, et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 1998;7:869-73. (Pubitemid 28471574)
36. Dreyer L, Olsen JH. Risk for non-smoking-related cancer in atherosclerotic patients. Cancer Epidemiol Biomarkers Prev 1999;8:915-8. (Pubitemid 29508728)
37. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556-65. (Pubitemid 47435820)
38. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007;86:s843-57.
39. Faber DR, van der Graaf Y, Westerink J, Visseren FL. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Atherosclerosis 2010;212:274-80.
40. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008;57:1269-75.
41. Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan RS, O'Donnell CJ, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009;32:481-5.
42. Inoue M, Noda M, Kurahashi N, Iwasaki M, Sasazuki S, Iso H, et al. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 2009;18:240-7.
43. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293-7.
44. Hull M, Kant P. Atherosclerosis and colorectal carcinogenesis: shared risk factors or common pathogenesis? Digestion 2010;81:16-7.
45. van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995;31A:1822-9.